Detalhe da pesquisa
1.
Empagliflozin protects mice against diet-induced obesity, insulin resistance and hepatic steatosis.
Diabetologia
; 66(4): 754-767, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525084
2.
Adipocyte GPX4 protects against inflammation, hepatic insulin resistance and metabolic dysregulation.
Int J Obes (Lond)
; 46(5): 951-959, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35031697
3.
100 years of inherited metabolic disorders in Austria-A national registry of minimal birth prevalence, diagnosis, and clinical outcome of inborn errors of metabolism in Austria between 1921 and 2021.
J Inherit Metab Dis
; 45(2): 144-156, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34595757
4.
Apolipoprotein A5 controls fructose-induced metabolic dysregulation in mice.
Nutr Metab Cardiovasc Dis
; 31(3): 972-978, 2021 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33549451
5.
Exocrine Pancreatic Insufficiency in Type 1 and Type 2 Diabetes.
Curr Diab Rep
; 20(6): 18, 2020 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32239341
6.
Dipeptidyl peptidase-4 impairs insulin signaling and promotes lipid accumulation in hepatocytes.
Biochem Biophys Res Commun
; 485(2): 366-371, 2017 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28213130
7.
Changing the dietary composition improves inflammation but not adipocyte thermogenesis in diet-induced obese mice.
J Nutr Biochem
; 99: 108837, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34419570
8.
Cardioprotective effects of short-term empagliflozin treatment in db/db mice.
Sci Rep
; 10(1): 19686, 2020 11 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33184414